Cited by 229Menopause: Health Impacts and TreatmentsHormonal and reproductive studiesEstrogen and related hormone effects

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Patient-Specific Decisions About Hormone Replacement Therapy in Postmenopausal Women

Col, Nananda F.·1997·JAMA: The Journal of the American Medical Association

DOI 10.1001/jama.1997.03540380054031

Open this paper in CoChat — free account

Abstract

Objective To examine the effect of hormone replacement therapy on life expectancy in postmenopausal women with different risk profiles for heart disease, breast cancer, and hip fracture. Design Decision analysis using a Markov model. Published regression models were used to link risk factors to disease incidence and to estimate the lifetime risks of developing coronary heart disease (CHD), breast cancer, hip fracture, and endometrial cancer. The impact of hormone therapy on disease incidence was estimated from published epidemiologic studies. Setting Mathematical model applicable to primary care. Interventions Treatment with hormone replacement therapy or no hormone replacement therapy. Main outcome measure Life expectancy. Results Hormone replacement therapy should increase life expectancy for nearly all postmenopausal women, with some gains exceeding 3 years, depending mainly on an individual's risk factors for CHD and breast cancer. For women with at least 1 risk factor for CHD, hormone therapy should extend life expectancy, even for women having first-degree relatives with breast cancer. Women without any risk factors for CHD or hip fracture, but who have 2 first-degree relatives with breast cancer, however, should not receive hormone therapy. Conclusions The benefit of hormone replacement therapy in reducing the likelihood of developing CHD appears to outweigh the risk of breast cancer for nearly all women in whom this treatment might be considered. Our analysis supports…

Integrity signals

Registry

Crossref · 10.1001/jama.1997.03540380054031

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Hip fractures in the elderly: A world-wide projection
Cooper, C. C., Campion, G., & Melton, L. J. (1992) · Osteoporosis International · doi:10.1007/bf01623184 · Cited by 3,225
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D. M., Ettinger, B. B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,329
Untitled work
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163
Postmenopausal Estrogen Therapy and Cardiovascular Disease
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 2,000
An updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
Stampfer, M. J., & Colditz, G. A. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90006-p · Cited by 1,611
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487

Show all 101 references

Sorted by citations

Dietary Isoflavones: Biological Effects and Relevance to Human Health
Setchell, K. D. R., & Cassidy, A. (1999) · Journal of Nutrition · doi:10.1093/jn/129.3.758s · Cited by 1,163
Cardiovascular Disease in Women
Mosca, L. J., Manson, J. E., Sutherland, S. E., Langer, R. D., Manolio, T. A., & Barrett-Connor, E. L. (1997) · Circulation · doi:10.1161/01.cir.96.7.2468 · Cited by 733
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
Walsh, B. W. (1998) · JAMA · doi:10.1001/jama.279.18.1445 · Cited by 691
The Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases
Redelmeier, D. A., Tan, S. H., & Booth, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382106 · Cited by 634
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
Barrett-Connor, E. L., & Grady, D. G. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.55 · Cited by 586
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.014 · Cited by 495
The menopause
Greendale, G. A., Lee, N. P., & Arriola, E. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05352-5 · Cited by 467
KEEPS: The Kronos Early Estrogen Prevention Study
Harman, S. M., Brinton, E., Cedars, M. I., Løbo, R. A., Manson, J., Merriam, G. R., Miller, V., Naftolin, F. N., & Santoro, N. F. (2005) · Climacteric · doi:10.1080/13697130500042417 · Cited by 396
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
Pfeilschifter, J., & Diel, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1570 · Cited by 362
Postmenopausal syndrome
Dalal, P., & Agarwal, M. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.161483 · Cited by 382
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Medical Decision Making · doi:10.1177/0272989x12455463 · Cited by 348
Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Keating, N. L., Cleary, P. D., Rossi, A. S., Zaslavsky, A. M., & Ayanian, J. Z. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00002 · Cited by 329
Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results
Haas, J. S., Kaplan, C. P., Gerstenberger, E. P., & Kerlikowske, K. M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00009 · Cited by 314
Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy
Hlatky, M. A., Boothroyd, D. B., Vittinghoff, E., Sharp, P. C., & Whooley, M. A. (2002) · JAMA · doi:10.1001/jama.287.5.591 · Cited by 302
Randomized Trial of a Portable, Self-administered Decision Aid for Postmenopausal Women Considering Long-term Preventive Hormone Therapy
O'Connor, A. M. C., Tugwell, P., Wells, G. A., Elmslie, T., JOLLY, E. E., Hollingworth, G. R., McPherson, R., Drake, E. R., Hopman, W. M., & Mackenzie, T. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800307 · Cited by 248
Primary Care for Survivors of Breast Cancer
Burstein, H. J., & Winer, E. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431506 · Cited by 241
Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration
Espeland, M. A., Marcovina, S. M., Miller, V. T., Wood, P. D., Wasilauskas, C. H., Sherwin, R. W., Schrott, H. G., & Bush, T. L. (1998) · Circulation · doi:10.1161/01.cir.97.10.979 · Cited by 186
The physiology, medical management and oral implications of menopause
Friedlander, A. H. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0025 · Cited by 166
Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis
Armstrong, K., Schwartz, J. S., Randall, T. C., Rubin, S. C., & Weber, B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.090 · Cited by 161
Identifying patient preferences for communicating risk estimates: A descriptive pilot study
Fortin, J. M., Hirota, L. K., Bond, B., O'Connor, A. M. C., & Col, N. F. (2001) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-1-2 · Cited by 153
Self-citation
Estrogen interacts with the IGF‐1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6‐hydroxdopamine lesions
Quesada, A., & Micevych, P. E. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10833 · Cited by 147
Hormone Replacement Therapy and Heart Disease Prevention
Petitti, D. B. (1998) · JAMA · doi:10.1001/jama.280.7.650 · Cited by 142
Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)
Miller, V. M., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hodis, H. N., Løbo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F. N., et al. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9104-y · Cited by 139
LY353381.HCl: A Novel Raloxifene Analog with Improved SERM Potency and Efficacy In Vivo
Sato, M., Turner, C. H., Wang, T., Adrian, M. D., Rowley, E. R., & Bryant, H. U. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37755-9 · Cited by 134
Postmenopausal hormone therapy: risks and benefits
Rozenberg, S., Vandromme, J., & Antoine, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.17 · Cited by 132
Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study
Schairer, C., Gail, M. H., Byrne, C., Rosenberg, P. S., Sturgeon, S. R., Brinton, L. A., & Hoover, R. N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.264 · Cited by 124
Prescribing for Seniors
Rochon, P. A. (1999) · JAMA · doi:10.1001/jama.282.2.113 · Cited by 123
Where Are We Going?
Santoro, N. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5765-1 · Cited by 122
Decision analysis and the implementation of research findings
Lilford, R. J., Pauker, S. G., Braunholtz, D., & Chard, J. (1998) · BMJ · doi:10.1136/bmj.317.7155.405 · Cited by 116
Timing and Duration of Menopausal Hormone Treatment May Affect Cardiovascular Outcomes
Harman, S. M., Vittinghoff, E., Brinton, E. A., Budoff, M. J., Cedars, M. I., Løbo, R. A., Merriam, G. R., Miller, V. M., Naftolin, F. N., Pal, L., et al. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.09.021 · Cited by 114
Development and pilot testing of a decision aid for postmenopausal women with osteoporosis
Cranney, A., O'Connor, A. M. C., Jacobsen, M. J., Tugwell, P., Adachi, J. D., Ooi, D. S., Waldegger, L., Goldstein, R., & Wells, G. A. (2002) · Patient Education and Counseling · doi:10.1016/s0738-3991(01)00218-x · Cited by 105
MENOPAUSE AND HORMONE REPLACEMENT THERAPY
Johnson, S. R. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70608-8 · Cited by 104
Is the Estrogen Controversy Over? Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence
Harman, S. M., Naftolin, F. N., Brinton, E. A., & Judelson, D. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.004 · Cited by 96
The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease
Mosca, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2263 · Cited by 87
Healthcare Use among U.S. Women Aged 45 and Older: Total Costs and Costs for Selected Postmenopausal Health Risks
Hoerger, T. J., DOWNS, K. E., Lakshmanan, M. C., Lindrooth, R. C., Plouffe, L., Wendling, B. W., West, S. L., & Ohsfeldt, R. L. (1999) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/jwh.1.1999.8.1077 · Cited by 78
The pharmacokinetics and efficacy of different estrogens are not equivalent
Ansbacher, R. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.109656 · Cited by 72
Current perspectives on benefits and risks of hormone replacement therapy
Burkman, R. T., Collins, J. A., & Greene, R. A. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117414 · Cited by 71
A randomized trial of a computerized versus an audio-booklet decision aid for women considering post-menopausal hormone replacement therapy
Rostom, A., O'Connor, A. M. C., Tugwell, P., & Wells, G. A. (2002) · Patient Education and Counseling · doi:10.1016/s0738-3991(01)00167-7 · Cited by 71
Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK
Daya, S., Ledger, W. J., Auray, J., Duru, G., Silverberg, K. M., Wikland, M., Bouzayen, R., Howles, C. M., & Béresniak, A. (2001) · Human Reproduction · doi:10.1093/humrep/16.12.2563 · Cited by 66
Prescribing Hormone Replacement Therapy for Menopausal Symptoms
McNagny, S. E. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-8-199910190-00010 · Cited by 65
Benefits and harms associated with hormone replacement therapy: clinical decision analysis
Minelli, C., Abrams, K. R., Sutton, A. J., & Cooper, N. J. (2004) · BMJ · doi:10.1136/bmj.328.7436.371 · Cited by 63
Role of Estrogens in the Management of Postmenopausal Bone Loss
Gallagher, J. C. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70191-5 · Cited by 62
Is the WHI Relevant to HRT Started in the Perimenopause?
Harman, S. M., Brinton, E. A., Clarkson, T. B., Heward, C. B., Hecht, H. S., Karas, R. H., Judelson, D. R., & Naftolin, F. N. (2004) · Endocrine · doi:10.1385/endo:24:3:195 · Cited by 58
Phyto-oestrogens through the life cycle
Cassidy, A., & Faughnan, M. S. (2000) · Proceedings of The Nutrition Society · doi:10.1017/s0029665100000719 · Cited by 59
Individualizing Therapy to Prevent Long-term Consequences of Estrogen Deficiency in Postmenopausal Women
Col, N. F., Pauker, S. G., Goldberg, R. J., Eckman, M. H., Orr, R. K., Ross, E. M., & Wong, J. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.13.1458 · Cited by 56
Self-citation
Healthy Women with a Family History of Breast Cancer: Impact of a Tailored Genetic Counseling Intervention on Risk Perception, Knowledge, and Menopausal Therapy Decision Making
Matloff, E. T., Moyer, A. E., Shannon, K. M., Niendorf, K. B., & Col, N. F. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.843 · Cited by 56
Self-citation
The impact of clinical trials on the use of hormone replacement therapy
Kim, N. V., Gross, C. P., Curtis, J. P., Stettin, G., Wogen, S. E., Choe, N., & Krumholz, H. M. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0221.x · Cited by 54
Economic Evaluation of Weight Loss Interventions in Overweight and Obese Women
Roux, L., Kuntz, K. M., Donaldson, C., & Goldie, S. J. (2006) · Obesity · doi:10.1038/oby.2006.125 · Cited by 56
The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease
Sbarouni, E., Kyriakides, Z. S., & Kremastinos, D. T. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00413-6 · Cited by 52
Bioidentical hormones, menopausal women, and the lure of the “natural” in U.S. anti-aging medicine
Fishman, J. R., Flatt, M. A., & Settersten, R. A. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.02.027 · Cited by 51
Low rates of hormone replacement in visits to United States primary care physicians
Stafford, R. S., Saglam, D., Causino, N., & Blumenthal, D. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70202-3 · Cited by 51
Soybean Isoflavones: Effects of Processing and Health Benefits
Faraj, A. K., & Vasanthan, T. (2004) · Food Reviews International · doi:10.1081/fri-120028830 · Cited by 48
A Mouse Model to Study the Effects of Hormone Replacement Therapy on Normal Mammary Gland during Menopause: Enhanced Proliferative Response to Estrogen in Late Postmenopausal Mice
Raafat, A. M., Hofseth, L. J., Li, S., Bennett, J. M., & Haslam, S. Z. (1999) · Endocrinology · doi:10.1210/en.140.6.2570 · Cited by 48
Avaliação tecnológica em saúde: densitometria óssea e terapêuticas alternativas na osteoporose pós-menopausa
Silva, L. K. (2003) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2003000400022 · Cited by 47
Menopausal hormones and breast cancer in a biracial population
Moorman, P. G., Kuwabara, H., Millikan, R. C., & Newman, B. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.6.966 · Cited by 47
Gynecological health of females with congenital heart disease
Canobbio, M. M., Perloff, J. K., & Rapkin, A. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.021 · Cited by 47
Phyto-oestrogens: A potential role in the prevention of CHD?
Cassidy, A., & Griffin, B. A. (1999) · Proceedings of The Nutrition Society · doi:10.1079/pns19990025 · Cited by 46
The effects of a soy rich diet on serum lipids: the Menfis randomized trial
Chiechi, L. M., Secreto, G., Vimercati, A., Greco, P., Venturelli, E., Pansini, F. S., Fanelli, M., Loizzi, P., & Selvaggi, L. E. (2002) · Maturitas · doi:10.1016/s0378-5122(01)00259-6 · Cited by 44
Progress in osteoporosis and fracture prevention: focus on postmenopausal women
Saag, K. G., & Geusens, P. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2815 · Cited by 47
LY353381·HCl: An Improved Benzothiophene Analog with Bone Efficacy Complementary to Parathyroid Hormone-(1–34)
Sato, M., Zeng, G. Q., Rowley, E. R., & Turner, C. H. (1998) · Endocrinology · doi:10.1210/endo.139.11.6307 · Cited by 45
The Proliferation of Clinical Practice Guidelines: Professional Development or Medicine-by-Numbers?
Genuis, S. J. (2005) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.18.5.419 · Cited by 41
Medical Decision Making
Elstein, A. S., Schwartz, A., & NENDAZ, M. R. (2002) · Springer international handbooks of education · doi:10.1007/978-94-010-0462-6_9 · Cited by 45
Elements of Informed Consent for Hormone Replacement Therapy in Patients With Diagnosed Breast Cancer
Chlebowski, R. T., & McTiernan, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.130 · Cited by 42
Selective oestrogen receptor modulators - current and future brain and behaviour applications
Halbreich, U. M., & Kahn, L. S. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.7.1385 · Cited by 40
Estrogen Replacement Therapy and Breast Cancer: Analysis of Age of Onset and Tumor Characteristics
Bilimoria, M. M., Winchester, D. J., Sener, S. F., Motykie, G. D., Sehgal, U. L., & Winchester, D. P. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0200-7 · Cited by 40
Hormone Replacement Therapy: Real Concerns and False Alarms
Bluming, A. Z., & Tavris, C. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e31819e332a · Cited by 40
Life With and Without Heart Disease Among Women and Men Over 50
Crimmins, E. M., Hayward, M. D., Ueda, H., Saito, Y., & Kim, J. K. (2008) · Journal of Women & Aging · doi:10.1300/j074v20n01_02 · Cited by 37
Can Computerized Decision Support Help Patients Make Complex Treatment Decisions? A Randomized Controlled Trial of an Individualized Menopause Decision Aid
Col, N. F., Ngo, L. H., Fortin, J. M., Goldberg, R. J., & O'Connor, A. M. C. (2007) · Medical Decision Making · doi:10.1177/0272989x07306781 · Cited by 37
Self-citation
Estradiol and Dydrogesterone
Foster, R. H., & Balfour, J. A. B. (1997) · Drugs & Aging · doi:10.2165/00002512-199711040-00006 · Cited by 36
Short-term Menopausal Hormone Therapy for Symptom Relief
Col, N. F., Weber, G. M., Stiggelbout, A. M., Chuo, J., D’Agostino, R. B., & Corso, P. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1634 · Cited by 35
Self-citation
Women's midlife health Reframing menopause
Rousseau, M. E. (1998) · Journal of Nurse-Midwifery · doi:10.1016/s0091-2182(98)00005-6 · Cited by 35
Antioxidant effect of estrogen on bovine aortic endothelial cells
Song, J., Kim, M., Jo, H.-H., Hwang, S.-J., Chae, B., Chung, J., Kwon, D.-J., Lew, Y.-O., Lim, Y.-T., Kim, J.-H., et al. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.07.006 · Cited by 34
Shared medical decision-making: A new paradigm for behavioral medicine—1997 presidential address
Kaplan, R. M. (1999) · Annals of Behavioral Medicine · doi:10.1007/bf02895027 · Cited by 33
Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding
Archer, D. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01036-x · Cited by 32
Raloxifene has favorable effects on the lipid profile in women explaining its beneficial effect on cardiovascular risk: A meta-analysis of randomized controlled trials
Yang, F., Li, N., Găman, M., & Wang, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105512 · Cited by 31
Cardiac Norepinephrine Release: Modulation by Ovariectomy and Estrogen
Eskin, B. A., Snyder, D. L., Roberts, J., & Aloyo, V. J. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800210 · Cited by 31
Menopause: Irish Women’s Voices
Carolan, M. C. (2000) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2000.tb02062.x · Cited by 30
Prevention and Treatment of Osteoporosis: Does the Future Belong to Hormone Replacement Therapy?
Gibaldi, M. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04292.x · Cited by 30
An integrated approach: bisphosphonate management for the treatment of osteoporosis.
Owens, G. M., Jackson, R. D., & Lewiecki, E. M. (2007) · PubMed · Cited by 28
Physician Specialty Is Significantly Associated With Hormone Replacement Therapy Use
Levy, B. T., Ritchie, J. M., Smith, E., Gray, T., & Zhang, W. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02381-5 · Cited by 28
Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum
Harman, S. M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.042 · Cited by 27
Hormone Replacement Therapy After Breast Cancer
Bluming, A. Z. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000595 · Cited by 28
Migraine, Menopause and Hormonal Replacement Therapy
Silberstein, S. D., & Lignieres, B. D. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00044.x · Cited by 27
Low use of long‐term hormone replacement therapy in Denmark
Olesen, C., Steffensen, F. H., Sørensen, H. T., Nielsen, G. L., Olsen, J., & Bergman, U. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00879.x · Cited by 27
Has the Impact of Hormone Replacement Therapy on Health-Related Quality of Life Been Undervalued?
Tosteson, A. N. A., Gabriel, S. E., Kneeland, T. S., Moncur, M. M., Manganiello, P. D., Schiff, I., Ettinger, B. B., & Melton, L. J. (2000) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460900318614 · Cited by 26
Menopausal hormone therapy decisions: insights from a multi-attribute model
Schapira, M. M. (2003) · Patient Education and Counseling · doi:10.1016/s0738-3991(02)00266-5 · Cited by 25
Acute hazards to young children from residential pesticide exposures
Spann, M. F., Blondell, J. M., & Hunting, K. L. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.6.971 · Cited by 24
Hispanic Women's Experience With “el Cambio de Vida”
Longworth, J. C. D. (2003) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2003.tb00397.x · Cited by 23
Women's perceptions of hormone replacement therapy: risks and benefits (1980–2002). A literature review
Buick, D. L., Crook, D., & Horne, R. (2005) · Climacteric · doi:10.1080/13697130500062654 · Cited by 24
Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women
Dias, A. S. M., Melo, R., Gebara, O., D’Amico, É. A., Nussbacher, A., Halbe, H. W., & Pinotti, J. (2005) · Climacteric · doi:10.1080/13697130500042581 · Cited by 24
Hormone replacement therapy: a time for pause.
Yusuf, S., & Anand, S. S. (2002) · Europe PMC (PubMed Central) · Cited by 24
Causal interpretation of correlational studies – Analysis of medical news on the website of the official journal for German physicians
Buhse, S., Rahn, A. C., Bock, M., & Mühlhauser, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196833 · Cited by 26
Does Estrogen Adequately Protect Postmenopausal Women Against Osteoporosis: An Iconoclastic Perspective
ORWOLL, E. S., & Nelson, H. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1872 · Cited by 23
Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it
Ekström, H. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.01.010 · Cited by 23
Relative Versus Attributable Risk of Breast Cancer from Estrogen Replacement Therapy
Santen, R. J., & Petroni, G. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1875 · Cited by 22
Raloxifene Versus Continuous Combined Estrogen/Progestin Therapy: Densitometric and Biochemical Effects in Healthy Postmenopausal Taiwanese Women
Tsai, K., Yen, M., Pan, H., Wu, M., Cheng, W., Hsu, S. H.-J., Yen, B. L., & Huang, K. E. (2001) · Osteoporosis International · doi:10.1007/s001980170011 · Cited by 22
Measuring improved patient choice
Holmes-Rovner, M. M., & Rovner, D. R. (2000) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.2000.00258.x · Cited by 21
Primary Prevention of Postmenopausal Osteoporosis
Levinson, W. S. (1998) · JAMA · doi:10.1001/jama.280.21.1821 · Cited by 21
Beliefs about Breast Cancer Risk and Use of Postmenopausal Hormone Replacement Therapy
Armstrong, K., Popik, S., Guerra, C. E., & Ubel, P. A. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000307 · Cited by 21
Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause
Kaplan, B., Aschkenazi-Steinberg, S. O., Yogev, Y., Nahum, R., Sulkes, J., & Phisher, M. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200209000-00008 · Cited by 21

Authors: Col, N. F.
Affiliations: Tufts University (US)
Corresponding author: Col, Nananda F.
ORCID: Col, Nananda F.
Venue: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association (AMA)
Published: 1997-04-09
Volume: 277
Issue: 14
Pages: 1140
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1997.03540380054031
OpenAlex: W1983608420
Cited by: 229
References: 101
Citations by year: 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 4
FWCI: 27.40
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: Agency for Healthcare Research and Quality (1 PO1 HS 06503)
U.S. National Library of Medicine (LM07092, T15LM007092)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: hormone replacement therapy, postmenopausal women, life expectancy, coronary artery disease, breast cancer, hip fracture, endometrial cancer, cardiovascular risk factors, family history of breast cancer, individualized treatment decision-making
MeSH terms: Aged, Breast Neoplasms, Coronary Disease, Decision Support Techniques, Female, Hip Fractures, Humans, Life Expectancy, Middle Aged, Models, Theoretical, Risk, Risk Factors, Sensitivity and Specificity, Estrogen Replacement Therapy, Endometrial Neoplasms, Postmenopause, Black People, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Patient-Specific Decisions About Hormone Replacement Therapy in Postmenopausal Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks